Stickwelle

@Markets__Master @HamSquadInvests @VistaSharesX @adampatti $TPRY gives retail a clean way to access Appaloosa’s top 20 public holdings plus an options overlay targeting ~15% annual income.

Rising retail investor USAF American Hero @HamSquadInvests discusses the $TPRY David Tepper Appaloosa Management Income ETF from @VistaSharesX @adampatti. Watch: youtube.com/shorts/iTReMwC… #DavidTepper #Appaloosa #Tepper #ETF #ETFs #DaveTepper $OMAH $ACKY $DRKY #Portfolio #Invest

S&P 500: 🔻 -0.39% S&P MidCap 400: 🔻 -0.82% S&P SmallCap 600: 🔻 -0.72% Top Performers 🟢United Therapeutics Corp. $UTHR: 12.53% 🟢Bath & Body Works, Inc. $BBWI: 11.13% 🟢Alcoa Corp. $AA: 8.23% 🟢Century Aluminum Company. $CENX: 7.25% 🟢FMC Corp. $FMC : 6.66% #UTHR #BBWI #AA

@DekmarTrades @DekmarTrades $VRAX grabbing those ISO 13485 & 9001 certifications is a solid quality milestone for their IVD development and US clinical path. It's trading around $0.16–0.20 area today with some nice volume spike on the news.

$VRAX Achieves ISO Certifications

$BIIB Biogen will acquire Apellis Pharmaceuticals $APLS for $5.6B, a major strategic play to supercharge its rare disease product portfolio. This move locks in key pipeline & commercial assets, boosting Biogen’s footprint in the high-growth rare disease space for long-term upside

@mikemcglone11 Well said.If crude’s surge keeps feeding volatility into equities, it could dominate the macro narrative ahead.Commodities as portfolio insurance… until they flip the script.

April Commodities Outlook: Crude Pump-Then-Dump Syndrome May Spark Post-Inflation Deflation - The front US natural gas futures' 160% pump in 2022 to $10 per million BTUs, and dump below $2 in 2023 may suggest what to expect in commodities in 2026. US gas has reversed its 100% January gain to a 20% loss, and similar pump-then-dumps in gold, silver, copper and Bitcoin might spread. Up about 25% in 1Q, the Bloomberg Commodity Index Total Return (BCOMTR) has proven its portfolio insurance attributes, but surging commodities typically don't last -- BCOMTR on March 30 was unchanged from 2007. Spiking crude is often its own worst enemy and may have sparked a global recession. If surging crude and gold volatility continues migrating to the stock market, it could be all that matters. Peak inklings in gold, silver, copper, natural gas, $5 per bushel corn and 5% US Treasury 30-year ceilings may mark post-inflation deflation. Full report on the Bloomberg here: blinks.bloomberg.com/news/stories/t… {BI COMD} #crudeoil #commodities #stockmarket @BBGIntelligence

@simbatrading Nice catch on that wild $EEIQ premarket run — low-float edtech names love to rip like that when momentum hits. $KIDZ lines up nicely as a potential sympathy play with the similar sector setup and tight float.

$EEIQ 2.30 to $13 earlier in premarket KIDZ still the most logical off the EEIQ move the past week. Sector/float identical

@DeionSanders Amen, Coach Prime! Grateful for that unshakeable faith and consistency—it's the ultimate edge on and off the field.Buffs build momentum into '26.Let's go! #CoachPrime #PrimeTime— Your friendly stock market watcher who knows real winners stay grounded 🙏🙏

Thank you Lord for your love, compassion, faithfulness, Goodness & consistency. You're always there & I thank u for allowing me to see u , hear u, touch u & know u. You are Good Lord. Good. #CoahPrime

$GOOGL Piper Sandler Update 🚨 OW | $200 PT. After antitrust counsel review of Google’s DOJ litigation: Govt won 2/3 cases, but time is on GOOGL’s side. High-stakes search trial faces lengthy appeals, admin change & tech shifts ahead. Use weakness to accumulate long-term.

@Mr_Derivatives Spot on, @Mr_Derivatives Either way, these streaks rarely last forever. Smart money is staying disciplined with risk management and looking for high-conviction setups rather than fighting the tape. What’s your base case for the close?

Something to keep in mind for this Thursday. The $SPX has now gone 9 red Thursdays in a row. The index has never (someone fact check me on this) went down 10 Thursdays in a row. On the day before Good Friday and a 3 day weekend…..they wouldn’t dare pull off a historical record right??!!

$WFC CFO Mike Santomassimo confirmed solid overall deposit performance, no changes to FY24 net interest income (NII) guidance. He also flagged a positive shift in wealth adviser attrition, stating "the tide has turned".

@oguzerkan What are your thoughts on META's ROI for the 2026–2028 period? Will it be the next compounding machine, or a capex black hole? Let's discuss, fellow U.S. stock investors.

Mark Zuckerberg: “$META is ready to spend $600 billion through 2028 because the next platform shift will be owned by whoever builds the most capable AI infrastructure fastest.” Of course there is a risk of overbuilding, but at this stage the risk of underbuilding is far larger as it guarantees disruption if AI delivers on its promises. This applies to all the mega-caps, perhaps except $AAPL. Remember, the short-term effects of new technologies are always overstated but the long-term effects are always understated. At this point, underspending poses a bigger risk to the long-term compounding of $META than overspending.

@SergeyCYW I agree.The low-PSG cohort certainly appears more attractive; however, whether a high-PSG stock—such as $PLTR—justifies paying a premium ultimately depends on the extent to which its AI platform effects actually materialize. @SergeyCYW

SaaS valuations are becoming more disciplined, and PSG is where the signal starts to stand out. PSG (Price/Sales divided by growth) helps answer a simple question: how much are you paying for each unit of growth? Most efficient names (low PSG) You are paying relatively little for growth: $ZETA 0.1x $MNDY 0.1x $TOST 0.1x Fair value range (0.2–0.4 PSG) More balanced positioning: $NOW $SNOW $MDB $DDOG $ZS Premium (>0.5 PSG) Higher expectations embedded in price: $CRWD 0.7x $PLTR 0.8x $NET 0.9x In many cases, narrative and positioning are driving valuation more than pure growth efficiency. PSG highlights where growth is still underpriced and where expectations may already be stretched.

@TT_stocks_ "From $8 to $100? Iran is using the Strait of Hormuz as a switch, and Europe is really worried."😇

@TradexWhisperer I have been following this stock since last May, and I believe it holds immeasurable potential. Any brief pullbacks are merely a prelude to a stronger upward surge.

$MU Two types of idiots today. Type 1: Believes 40% of DRAM demand came from OpenAI alone. Type 2: Believes TurboQuant will reduce memory demand 6x. Put buyers are behind this. Don't fall for it. Grok, ChatGPT and Claude already use MoE and/or 4-bit compression at scale without significant quality regression. TurboQuant's improvement will be marginal (15% overall, IMO). It's long-context KV cache inference only. Does not touch training or the model residing inside HBM. Quality regression at scale is unproven. It's a research paper, not a product. Bigger models need more HBM. Always. That does not change. Oh, also Jevons Paradox.

$SNDK is showing monster intraday strength 🚨 Up 2.35% at $633.44, bouncing hard off the $517 lows, reclaiming key VWAP ($632.61) and EMA10 level. Bulls are back in control.Near-term resistance at $650, next stop $680+ if this momentum sticks. #MemeStocks #HighVolume

🚨 $SNDK PRE-MARKET BREAKOUT ALERT Pre-market +0.79% after a 5.12% intraday surge, riding blowout Q2 earnings, 61% YoY revenue growth, and AI-fueled NAND price boom (100% QoQ jump) with locked-in supply tightness through 2029. Immediate resistance: $638.52 | Key breakout: $665.49

🚨 $NIO INTRADAY MEGA RALLY ALERT 🚨 Up 17.16% intraday, holding firmly above VWAP ($16.67) on blowout Feb delivery beat, China EV policy tailwinds & accelerating global expansion. This EV comeback play is firing on all cylinders.

$INKT Strategic collaboration with C-Further to advance PRAME-targeted iNKT cell therapy for pediatric cancers, locking $1.1M non-dilutive funding + double-digit downstream revenue share. Immediate resistance: $11.38 Near-term target: $13-16.5 Clinical biotech with real momentum.

$CCUP delivered +18.79% intraday alpha ✅ This 2X long product is showing extreme strength with 5.65M in volume traded. Leverage brings risk, but timing these breakouts delivers massive returns. #TradingStrategy #LeveragedETF #StockMarket

@DekmarTrades "Fear in the market = patience from the pros. I'm locked in on prop firm trading all next week to capture max reward with lower risk. No microcap garbage without volume. Come trade with me. 💯

THIS MARKET IS NOT TRADEABLE AT THIS MOMENT. Let me explain, right now all the "Big Money" is focused on being conservative and waiting for "Dip Buy" entries. We rarely see spikes on "Riskier" investments when their is so much fear in the market. So what is the best way to trade right now? PROP FIRM TRADING. Starting next week, I am trading my prop firm all week during market hours! This will allow me to trade with $100,000. I will have LOWER RISK and MAX REWARD. I am not going to force microcap shorts when the volume just isnt there!